WilmerHale Adds FDA Regulatory Partner O’Brien in Washington DC

George O’Brien joined WilmerHale as a partner in its regulatory and government affairs department in Washington DC, the firm announced Monday.

O’Brien advises life sciences companies on the development, approval and commercialization of products regulated by the FDA, including drugs and biologics, medical devices, food and beverage products, dietary supplements, infant formula, and cosmetics products. His practice spans regulatory counseling throughout the product lifecycle, regulatory support for corporate and transactional matters, and strategic regulatory advice for enforcement, investigations, and litigation, the firm said.

He joins from Mayer Brown, according to his LinkedIn profile.

This story was produced by Bloomberg Law ...